Literature DB >> 27052993

Central Line-Associated Bloodstream Infection Reduction and Bundle Compliance in Intensive Care Units: A National Study.

E Yoko Furuya1, Andrew W Dick2, Carolyn T A Herzig3, Monika Pogorzelska-Maziarz4, Elaine L Larson3, Patricia W Stone3.   

Abstract

OBJECTIVES To describe compliance with the central line (CL) insertion bundle overall and with individual bundle elements in US adult intensive care units (ICUs) and to determine the relationship between bundle compliance and central line-associated bloodstream infection (CLABSI) rates. DESIGN Cross-sectional study. PARTICIPANTS National sample of adult ICUs participating in National Healthcare Safety Network (NHSN) surveillance. METHODS Hospitals were surveyed to determine compliance with CL insertion bundle elements in ICUs. Corresponding NHSN ICU CLABSI rates were obtained. Multivariate Poisson regression models were used to assess associations between CL bundle compliance and CLABSI rates, controlling for hospital and ICU characteristics. RESULTS A total of 984 adult ICUs in 632 hospitals were included. Most ICUs had CL bundle policies, but only 69% reported excellent compliance (≥95%) with at least 1 element. Lower CLABSI rates were associated with compliance with just 1 element (incidence rate ratio [IRR] 0.77; 95% confidence interval [CI], 0.64-0.92); however, ≥95% compliance with all 5 elements was associated with the greatest reduction (IRR, 0.67; 95% CI, 0.59-0.77). There was no association between CLABSI rates and simply having a written CL bundle policy nor with bundle compliance <75%. Additionally, better-resourced infection prevention departments were associated with lower CLABSI rates. CONCLUSIONS Our findings demonstrate the impact of transferring infection prevention interventions to the real-world setting. Compliance with the entire bundle was most effective, although excellent compliance with even 1 bundle element was associated with lower CLABSI rates. The variability in compliance across ICUs suggests that, at the national level, there is still room for improvement in CLABSI reduction. Infect Control Hosp Epidemiol 2016;37:805-810.

Entities:  

Mesh:

Year:  2016        PMID: 27052993      PMCID: PMC4939802          DOI: 10.1017/ice.2016.67

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  11 in total

1.  Using a bundle approach to improve ventilator care processes and reduce ventilator-associated pneumonia.

Authors:  Roger Resar; Peter Pronovost; Carol Haraden; Terri Simmonds; Thomas Rainey; Thomas Nolan
Journal:  Jt Comm J Qual Patient Saf       Date:  2005-05

2.  An intervention to decrease catheter-related bloodstream infections in the ICU.

Authors:  Peter Pronovost; Dale Needham; Sean Berenholtz; David Sinopoli; Haitao Chu; Sara Cosgrove; Bryan Sexton; Robert Hyzy; Robert Welsh; Gary Roth; Joseph Bander; John Kepros; Christine Goeschel
Journal:  N Engl J Med       Date:  2006-12-28       Impact factor: 91.245

3.  The 100,000 lives campaign: setting a goal and a deadline for improving health care quality.

Authors:  Donald M Berwick; David R Calkins; C Joseph McCannon; Andrew D Hackbarth
Journal:  JAMA       Date:  2006-01-18       Impact factor: 56.272

4.  The CLABs collaborative: a regionwide effort to improve the quality of care in hospitals.

Authors:  Brian S Koll; Terri A Straub; Hillary S Jalon; Rachel Block; Karen S Heller; Rafael E Ruiz
Journal:  Jt Comm J Qual Patient Saf       Date:  2008-12

5.  Reduction of central line infections in Veterans Administration intensive care units: an observational cohort using a central infrastructure to support learning and improvement.

Authors:  Marta L Render; Rachael Hasselbeck; Ron W Freyberg; Timothy P Hofer; Anne E Sales; Peter L Almenoff
Journal:  BMJ Qual Saf       Date:  2011-04-02       Impact factor: 7.035

6.  State of infection prevention in US hospitals enrolled in the National Health and Safety Network.

Authors:  Patricia W Stone; Monika Pogorzelska-Maziarz; Carolyn T A Herzig; Lindsey M Weiner; E Yoko Furuya; Andrew Dick; Elaine Larson
Journal:  Am J Infect Control       Date:  2014-02       Impact factor: 2.918

7.  Estimating health care-associated infections and deaths in U.S. hospitals, 2002.

Authors:  R Monina Klevens; Jonathan R Edwards; Chesley L Richards; Teresa C Horan; Robert P Gaynes; Daniel A Pollock; Denise M Cardo
Journal:  Public Health Rep       Date:  2007 Mar-Apr       Impact factor: 2.792

8.  Raising standards while watching the bottom line: making a business case for infection control.

Authors:  Eli N Perencevich; Patricia W Stone; Sharon B Wright; Yehuda Carmeli; David N Fisman; Sara E Cosgrove
Journal:  Infect Control Hosp Epidemiol       Date:  2007-10       Impact factor: 3.254

9.  'Matching Michigan': a 2-year stepped interventional programme to minimise central venous catheter-blood stream infections in intensive care units in England.

Authors:  Julian Bion; Annette Richardson; Peter Hibbert; Jeanette Beer; Tracy Abrusci; Martin McCutcheon; Jane Cassidy; Jane Eddleston; Kevin Gunning; Geoff Bellingan; Mark Patten; David Harrison
Journal:  BMJ Qual Saf       Date:  2012-09-20       Impact factor: 7.035

10.  Central line bundle implementation in US intensive care units and impact on bloodstream infections.

Authors:  E Yoko Furuya; Andrew Dick; Eli N Perencevich; Monika Pogorzelska; Donald Goldmann; Patricia W Stone
Journal:  PLoS One       Date:  2011-01-18       Impact factor: 3.240

View more
  15 in total

1.  Concurrent Detection of Bacterial Pathogens in Hospital Roommates.

Authors:  Bevin Cohen; Christopher M Spirito; Jianfang Liu; Kenrick D Cato; Elaine Larson
Journal:  Nurs Res       Date:  2019 Jan/Feb       Impact factor: 2.381

2.  Long Overdue Need to Reduce Infections with Hemodialysis.

Authors:  Alan S Kliger; Allan J Collins
Journal:  Clin J Am Soc Nephrol       Date:  2017-10-03       Impact factor: 8.237

3.  Presence of Invasive Devices and Risks of Healthcare-Associated Infections and Sepsis.

Authors:  Erin E Bennett; John VanBuren; Richard Holubkov; Susan L Bratton
Journal:  J Pediatr Intensive Care       Date:  2018-05-23

4.  Investigation and Analysis of Infection among Inpatients in a Tertiary Hospital in Shanghai.

Authors:  Jiao Yu; Jing Wang; Xinying Fang; Feihu Huang
Journal:  Comput Math Methods Med       Date:  2022-06-28       Impact factor: 2.809

5.  Urinary catheter policies in home healthcare agencies and hospital transfers due to urinary tract infection.

Authors:  Jordan M Harrison; Andrew W Dick; Elizabeth A Madigan; E Yoko Furuya; Ashley M Chastain; Jingjing Shang
Journal:  Am J Infect Control       Date:  2021-12-07       Impact factor: 4.303

6.  Assessment of the Potential for Inducing Resistance in Multidrug-Resistant Organisms from Exposure to Minocycline, Rifampin, and Chlorhexidine Used To Treat Intravascular Devices.

Authors:  Joel Rosenblatt; Nylev Vargas-Cruz; Ruth A Reitzel; Issam I Raad
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

7.  Impact of a comprehensive care bundle educational program on device-associated infections in an emergency intensive care unit.

Authors:  Essamedin M Negm; Howaydah A Othman; Mohamed M Tawfeek; Marwa M Zalat; Rehab H El-Sokkary; Khaled M Alanwer
Journal:  Germs       Date:  2021-09-29

8.  The Effect of a Guide Based Application Bundle on the Catheter-Related Infection.

Authors:  Burcu Kübra Süha; Şerife Karagözoğlu
Journal:  Florence Nightingale Hemsire Derg       Date:  2019-10-01

9.  Changes in prevalence of nosocomial infection pre- and post-COVID-19 pandemic from a tertiary Hospital in China.

Authors:  Chunmei Su; Zhiqin Zhang; Xu Zhao; Hanlin Peng; Yi Hong; Lili Huang; Jie Huang; Xiangming Yan; Shuiyan Wu; Zhenjiang Bai
Journal:  BMC Infect Dis       Date:  2021-07-20       Impact factor: 3.090

10.  Health Care-Associated Infections Among Critically Ill Children in the US, 2013-2018.

Authors:  Heather E Hsu; Roshni Mathew; Rui Wang; Carly Broadwell; Kelly Horan; Robert Jin; Chanu Rhee; Grace M Lee
Journal:  JAMA Pediatr       Date:  2020-12-01       Impact factor: 16.193

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.